Q32 Bio (QTTB) Stock Chart & Stock Price History → Trump Reveals Conspiracy Behind Fed-Controlled Digital Currency. (From Monetary Gold) (Ad) Free QTTB Stock Alerts $28.42 +0.67 (+2.41%) (As of 05/14/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesOwnershipSEC FilingsSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesOwnershipSEC FilingsSocial Media Q32 Bio Stock Price Performance5 Day Performance+6.04%1 Month Performance-1.63% Receive QTTB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Q32 Bio and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Porter & CompanyAmerica’s worst nightmare?What This Group Has Planned for the 2024 Election Will Shock You Controversial new exposé reveals what’s really going on in America, what it means for your money, and what you must do to protect your assets before it’s too late.Click here to watch this bombshell exposé now. QTTB Stock Chart for Wednesday, May, 15, 2024 QTTB Chart by TradingView Q32 Bio Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/14/2024$27.75$28.42+2.41%$28.74$27.6838,810 shs$92.65 million05/13/2024$27.13$27.75+2.29%$27.90$26.7623,140 shs$90.47 million05/10/2024$26.80$27.13+1.23%$27.18$25.5530,129 shs$88.44 million05/09/2024$26.28$26.80+1.98%$27.50$24.1720,768 shs$87.37 million05/08/2024$27.19$26.28-3.35%$27.23$25.0410,278 shs$85.67 million05/07/2024$25.85$27.19+5.18%$27.57$25.2016,555 shs$88.64 million Get the Latest News and Ratings for QTTB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Q32 Bio and its competitors with MarketBeat's FREE daily newsletter. 05/06/2024$25.59$25.85+1.02%$26.91$24.1732,245 shs$84.17 million05/03/2024$25.77$25.59-0.70%$26.41$25.2513,508 shs$83.42 million05/02/2024$26.54$25.77-2.90%$26.44$25.3148,943 shs$84.01 million05/01/2024$27.40$26.54-3.14%$27.38$25.9015,145 shs$86.41 million04/30/2024$29.04$27.40-5.65%$29.77$27.0026,304 shs$89.32 million04/29/2024$28.02$29.04+3.64%$29.20$27.9927,248 shs$94.67 million04/26/2024$28.24$28.02-0.78%$28.89$27.5128,395 shs$91.35 million04/25/2024$26.59$28.24+6.21%$28.57$26.1737,613 shs$92.06 million04/24/2024$25.50$26.59+4.27%$26.77$24.9029,687 shs$86.68 million04/23/2024$24.82$25.50+2.74%$25.92$24.6540,476 shs$83.13 million04/22/2024$22.49$24.82+10.36%$25.20$21.2847,665 shs$80.81 million04/19/2024$24.38$22.49-7.75%$23.78$21.9922,642 shs$72.64 million04/18/2024$24.12$24.38+1.08%$24.76$23.1916,182 shs$78.75 million04/17/2024$24.99$24.12-3.48%$25.36$24.1238,807 shs$77.96 million04/16/2024$26.45$24.99-5.52%$26.91$24.7944,315 shs$80.72 million04/15/2024$28.89$26.45-8.45%$28.00$24.2097,742 shs$85.43 million04/12/2024$23.81$28.89+21.34%$30.92$25.60271,577 shs$93.32 million04/11/2024$21.48$23.81+10.85%$24.98$21.4581,621 shs$76.91 million04/10/2024$21.30$21.48+0.85%$21.70$20.9715,643 shs$69.38 million04/09/2024$21.42$21.30-0.56%$21.49$20.2912,737 shs$68.80 million04/08/2024$20.22$21.42+5.93%$21.67$20.2216,482 shs$69.19 million04/05/2024$20.71$20.22-2.37%$20.69$20.2012,689 shs$65.31 million04/04/2024$21.29$20.71-2.72%$21.91$20.6831,921 shs$66.89 million04/03/2024$21.98$21.29-3.14%$21.99$20.2452,162 shs$68.81 million04/02/2024$18.00$21.98+22.11%$22.79$18.86104,233 shs$71.00 million04/01/2024$17.04$18.00+5.63%$18.95$17.0524,883 shs$58.14 million03/29/2024$17.04$17.04$17.04$15.9728,549 shs$55.04 million03/28/2024N/A$17.04$17.04$15.9728,549 shs$55.04 million Related Companies: Aclaris Therapeutics Stock Chart Chimerix Stock Chart LifeVantage Stock Chart Vaccitech Stock Chart Barinthus Biotherapeutics Stock Chart YS Biopharma Stock Chart Oncolytics Biotech Stock Chart Spero Therapeutics Stock Chart Milestone Pharmaceuticals Stock Chart Connect Biopharma Stock Chart Receive QTTB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Q32 Bio and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:QTTB) was last updated on 5/15/2024 by MarketBeat.com Staff From Our PartnersHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportBiden to Drop BOMBSHELL June 13th?Paradigm PressTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaDemocrats Push to Replace Dollar With Digital Coin, Control Currency.Monetary GoldForget the “Magnificent 7” Tech Companies, Buy This AI Stock InsteadBanyan Hill Publishingis this a buy and hold stock?Tips4TradersWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks NewsThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeTrue Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Q32 Bio Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.